Samsung Biologics raises annual estimated earnings to W3.6t

Samsung Biologics has raised the full-year earnings estimate in its company guidance again to 3.6 trillion won ($2.6 billion) for this year, up some 20 percent from last year, according to its regulatory filing released on Wednesday.
It was the second time this year for Samsung Biologics to increase the estimate of its annual earnings. Earlier in April, the company raised its estimated earnings from sales to 3.52 trillion won.
“(Samsung Biologics) has readjusted (the estimated earnings in its) annual company guidance again, mainly based on large-sized contract manufacturing orders from international pharmaceutical companies this year,” an official from Samsung Biologics said.
In 2023, the company’s accumulated order value reached some 2.7 trillion won, backed by its large-scale contracts with Pfizer, Novartis and BMS.
Many of its clients, including GSK, Roche, Novartis, Pfizer and Eli Lilly, have also agreed with Samsung Biologics to expand their existing contract manufacturing deals, helping the company to post improved earnings this year.
The combined value of deals that have been expanded from existing deals has reached 986.2 billion won as of September, according to Samsung Biologics.
Samsung Biologics expects its earnings to improve particularly in the third quarter, in which revenue from the company’s fourth plant will start to be included.
“The utilization rate of the fourth plant has been increasing faster than expected,” the official from Samsung Biologics said.
相关文章
'Apgujeong Box Girl' sparks online debate
A woman walking around in a box in southern Seoul's popular Gangnam has sparked criticism onlin2023-12-08Seoul subway on verge of strike
Tensions are rising over the potential for a strike by Seoul Metro workers, as labor and management2023-12-08New book sheds light on ongoing debate and legacy of comfort women issues
The issue of women forced into Japanese military sex slavery during World War II, known euphemistica2023-12-08Foreigners turn net sellers of S. Korean stocks for 15 sessions
Foreign investors have dumped South Korean stocks for 15 consecutive trading days, the longest strea2023-12-08Seoul subway workers vote for strike plan
The possibility of a strike became reality, as a majority of Seoul Metro union members voted for a g2023-12-08Korea extends fuel tax cut scheme until year's end
The Korean government will extend the current tax cut imposed on fuel until the end of the year, the2023-12-08
最新评论